EXTRACELLULAR VESICLES AS MARKERS OF INFLAMMATION AND HYPERCOAGULABILITY DURING THE FIRST MONTH OF SARS-COV-2 INFECTION IN OUTPATIENTS AND HOSPITALIZED PATIENTS
Read
1122
Timeswas read the article
455
Total PDF
667
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 9 | 5 | 14 |
| 2025 6 | 34 | 14 | 48 |
| 2025 5 | 51 | 14 | 65 |
| 2025 4 | 29 | 8 | 37 |
| 2025 3 | 47 | 13 | 60 |
| 2025 2 | 34 | 15 | 49 |
| 2025 1 | 23 | 17 | 40 |
| 2024 12 | 23 | 16 | 39 |
| 2024 11 | 26 | 16 | 42 |
| 2024 10 | 32 | 18 | 50 |
| 2024 9 | 34 | 12 | 46 |
| 2024 8 | 44 | 24 | 68 |
| 2024 7 | 32 | 21 | 53 |
| 2024 6 | 29 | 19 | 48 |
| 2024 5 | 37 | 28 | 65 |
| 2024 4 | 29 | 15 | 44 |
| 2024 3 | 17 | 14 | 31 |
| 2024 2 | 15 | 18 | 33 |
| 2024 1 | 10 | 12 | 22 |
| 2023 12 | 10 | 15 | 25 |
| 2023 11 | 8 | 7 | 15 |
| 2023 10 | 11 | 24 | 35 |
| 2023 9 | 12 | 11 | 23 |
| 2023 8 | 7 | 19 | 26 |
| 2023 7 | 6 | 9 | 15 |
| 2023 6 | 9 | 14 | 23 |
| 2023 5 | 6 | 3 | 9 |
| 2023 4 | 4 | 8 | 12 |
| 2023 3 | 2 | 4 | 6 |
| 2023 2 | 5 | 9 | 14 |
| 2023 1 | 6 | 4 | 10 |
| 2022 12 | 7 | 13 | 20 |
| 2022 11 | 4 | 7 | 11 |
| 2022 10 | 15 | 9 | 24 |
Show all
